Related Experiment Video
Updated: May 12, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Resmetirom as an important cornerstone of multidisciplinary management of metabolic dysfunction-associated
1Department of Metabolic and Bariatric Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
No abstract available in PubMed .
More Related Videos
04:14Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Acute Pancreatitis II: Clinical Manifestations and Management
Oral Hypoglycemic Agents: Biguanides and Glitazones
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...